Will Technology Take Over Manpower?

Globally, the pharmaceutical industry is undergoing tremendous pressure to develop new research molecules for complex diseases. With rising healthcare demands and changing regulatory requirements, more is being expected from the industry to provide real-time monitoring of manufacturing processes. Parallelly, new tech trends are flooding the market and attracting companies by providing minimum error solutions. Due to complexities in R&D and risks involved in regulatory compliance, the pharma industry is willing to invest in building up tech-enabled solutions against enhancing their manpower capabilities. Experts analyse the changing conservative nature and highlights the opportunities.

- Usha Sharma

Data analytics, AI and IoT is going to change the entire R&D scenario in the next decade

It is very much true that Pharmaceutical companies are changing their focus to adoption of new technologies, there are reasons for this strategy. The market drivers of new technology are intense global competition, uncertainties in energy and supply costs, decreasing product life cycles and exponential growth in the IT sector. At the same time, there is a surge of the Pharma 4.0 concept globally. It is the latest wave of technological advances that will derive the next phase of pharmaceutical manufacturing. The pharma 4.0 broadly comprises the convergence of people, physical systems, and data within a process to improve productivity, quality, and profit by using the power of advanced data analytics. This evolution of advanced analytics is expected to improve insights into the science of making life-saving drugs. The data analytics, artificial intelligence, and IoT are going to change the entire research and development scenario in the next decade and are expected to reduce the time and the cost of the development considerably. The automation and technology create the opportunity to leverage data and analytics to improve the processes.